2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental VitiligoSkin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligoActive, not recruitingPhase 32026-09-28NCT06163326
Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative ComplicationsPathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative ComplicationsRecruitingNot stated2025-08-24NCT06386354